Page last updated: 2024-11-01

ondansetron and Rheumatic Diseases

ondansetron has been researched along with Rheumatic Diseases in 1 studies

Ondansetron: A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.

Rheumatic Diseases: Disorders of connective tissue, especially the joints and related structures, characterized by inflammation, degeneration, or metabolic derangement.

Research Excerpts

ExcerptRelevanceReference
"To study if acupuncture, combined with ondansetron treatment, reduces nausea and vomiting associated with cyclophosphamide infusion in patients with rheumatic diseases."5.10Acupuncture to reduce nausea during chemotherapy treatment of rheumatic diseases. ( Josefson, A; Kreuter, M, 2003)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Josefson, A1
Kreuter, M1

Trials

1 trial available for ondansetron and Rheumatic Diseases

ArticleYear
Acupuncture to reduce nausea during chemotherapy treatment of rheumatic diseases.
    Rheumatology (Oxford, England), 2003, Volume: 42, Issue:10

    Topics: Acupuncture Therapy; Adult; Aged; Antiemetics; Antirheumatic Agents; Combined Modality Therapy; Cycl

2003